Short Interest in Starpharma Holdings Ltd. (OTCMKTS:SPHRY) Rises By ∞

Starpharma Holdings Ltd. (OTCMKTS:SPHRY) was the recipient of a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 1 shares, a growth of ∞ from the May 31st total of 0 shares. Based on an average trading volume of 1,105 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Starpharma Stock Performance

Starpharma stock traded up $0.04 during mid-day trading on Tuesday, hitting $4.72. 4,256 shares of the company were exchanged, compared to its average volume of 2,162. The business has a fifty day moving average of $4.92 and a 200 day moving average of $3.63. Starpharma has a 1-year low of $0.55 and a 1-year high of $5.70.

About Starpharma

Starpharma is a clinical-stage biopharmaceutical company specializing in the development of dendrimer-based products across infectious disease, oncology and ophthalmology. Its proprietary dendrimer platform, DEP™ (Dendrimer Enhanced Products), enables precise molecular engineering to enhance drug delivery, targeting and safety profiles. The company’s lead product, VivaGel®, is a topical microbicide that has been approved in multiple markets for the treatment and prevention of bacterial vaginosis and is in clinical development for antiviral applications.

In addition to VivaGel, Starpharma is advancing pipeline candidates that leverage DEP technology to improve the performance of established and novel therapeutic agents.